A Senior Cancer Researcher Joins PhytoMedical Technologies, Inc. on Heels of Company’s Successful Preclinical Study on Human Brain Cancer

PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced the appointment of Li-Xi Yang, MD, PhD, an experienced scientist on the development of anti-cancer compounds, to the Company’s Advisory Board.
MORE ON THIS TOPIC